-
1
The 49th Annual Meeting of the European Society for Blood and Marrow Transplantation was held from April 23 to 26, 2023, in a hybrid format.
-
2
A study analyzed COVID-19 outcomes in allogeneic stem cell transplant patients, revealing improved survival rates over time despite ongoing risks.
-
3
Among 986 patients studied, 14.7% died, with only 1% of fully vaccinated patients succumbing to COVID-19, indicating vaccination's effectiveness.
-
4
Children showed better COVID-19 outcomes than adults, with significant risk factors identified for severe disease including age and immunosuppression.
-
5
The meeting featured presentations on CAR T-cell therapy, highlighting its transformative impact on relapsed/refractory chronic lymphocytic leukemia.
